ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood 2007;92:1143
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchetti, F.
Right arrow Articles by Ventura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchetti, F.
Right arrow Articles by Ventura, A.

Letters

Drugs for the treatment of gastro-oesophageal reflux: in search of clear evidence-based indications

Federico Marchetti, Jenny Bua, Alessandro Ventura

Department of Paediatrics, Institute of Child Health, IRCCS Burlo Garofolo, Trieste, Italy

Correspondence to:
Federico Marchetti, Department of Paediatrics, Institute of Child Health, IRCCS Burlo Garofolo, Trieste, Italy; fedemarche@tin.it

The first 150 words of the full text of this article appear below.

Keady1 presents some updated guidelines on the drug treatment of gastro-oesophageal reflux (GOR) and gastro-oesophageal reflux disease (GORD). However, in order to provide clear management guidelines, we believe that the review should have first addressed the definition of GOR (ie, physiological) versus GORD (ie, pathological). In fact, the results of a recent survey on the knowledge, attitudes and practice styles of North American paediatricians regarding GOR show that many infants are still inappropriately treated for GORD when all they have is physiological GOR.2 The first important goal of future educational efforts should therefore be directed to avoid over-treatment of "happy spitters" (ie, GOR). Secondly, in his conclusions Keady correctly stresses that "the majority of drugs used have limited robust data supporting their use". However, some evidence from randomised controlled trials (RCTs) is now available, but it is not clearly reflected by the practice guidelines suggested by Keady. An example of . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health